Congratulations to Calvin Johnson (CJ) as he takes on his new role as CEO of Camden portfolio company,
@RoshalImaging! We’re very much looking forward to partnering with CJ who brings extensive leadership experience as well as a history of driving growth.
Roshal Imaging is pleased to announce we have hired Calvin Johnson (CJ) as Chief Executive Officer, following a robust search process led by @CamdenPartners1. We’re looking forward to great things with him at the helm.
#ExecutiveLeadership #CEO #Healthcare
2
Congrats to Camden portfolio company @Catalyte_io on winning an @Inc Best in Business Award! Catalyte continues to transform software development with its use of #machinelearning & #predictiveanalytics to create a new, diverse generation of tech talent ow.ly/dfki50D3pNh
Camden Partners is excited to announce the recent closings of 3 new investments -- @eFileCabinet, @VollyTech, and Roshal Imaging Services. Be sure to check out the individual press releases ›› CamdenPartners.com/news
Camden is excited to announce the final close on its sixth private equity fund, a $100M growth equity fund investing in technology-enabled services and software, education, and business services companies in the lower-middle market.
Camden Partners retweeted
Excited to announce our participation in LifeSprout’s Series A round. LifeSprout is a @JohnsHopkins born biomaterials company, developing revolutionary products for aesthetic & regenerative medicine. bizjournals.com/baltimore/ne…
Camden Partners retweeted
We are pleased to announce our investment in @COMPASSPathway along with @foundersfund @ATAI_life & other great investors. In today's world, mental health is more important than ever, & COMPASS is leading the charge for next-gen therapies. fiercebiotech.com/biotech/co…
Camden is excited to announce the promotion of Calvin Young to Vice President! He has added value to a number of our existing portfolio companies and has been a key member of the deal team. Congratulations Calvin!
#movingonup #promotion #vicepresident #growth
1
Congrats to Camden's very own, @SukariBrown, for being selected for @HBCUvc's second class of the HBCUvc 31 Under 31 in Venture Capital List! Check out the complete list of 31 leaders >> ow.ly/BkH950yCMm4 >> #emergingtalent
1
We're excited to announce the launch of our new website! Be sure to check out the newly designed camdenpartners.com! @CamdenNexus
#newwebsite #officiallylaunched #brandrefresh
We're proud to announce @CamdenNexus Co-Founder, @georgecpetro, was appointed to the Board of Directors of @KennedyKrieger Institute! <> ow.ly/ErXl50x69PG
Be sure to stop by Camden’s photo booth at Beta City tonight! #betacity
1
Come join CP Partner, Jason Tagler, one of the judges at this year's Beta City Venture Capital Pitch Competition! We hope to see you there!
@betamore #betacity #citygarage
1
Camden Partners retweeted
Congrats to Nexus Venture Partner Bert Vogelstein on being awarded the 2019 Albany Medical Center Prize in Medicine and Biomedical Research for his role in discovering the genetic basis of cancer! @AlbanyMed @HHMINEWS @HopkinsMedicine
amc.edu/news/innovators-who-…
Camden Partners retweeted
.@ExactSciences, co-founded by Nexus Venture Partner Bert Vogelstein, announces the purchase of Genomic Health to add breast and prostate cancer tests to complement its breakthrough Cologuard test for colon cancer
bloomberg.com/news/articles/…
We're proud to congratulate Camden Operating Partner, @RichelleParham, for being recognized as one of @savoynetwork's 2019 Most Influential Women in Corporate America! ›› ow.ly/bvr450vbOCI
Camden Partners retweeted
New diagnostic tests developed by Nexus Venture Partner Bert Vogelstein at @HopkinsMedicine and licensed to Nexus portfolio company Thrive Earlier Detection could eliminate unnecessary surgery for patients with pancreatic cysts. spectrum.ieee.org/the-human-…
For the first time ever, majority of @MIT engineering department heads are women. We're proud of @CamdenNexus Venture Partner, Paula Hammond of @MITChemE, who is among this group of role models. #WomenInEngineering
ow.ly/Hxtg50uVQhe
Exciting work by @CamdenNexus Venture Partners Elliot Fishman and Bert Vogelstein at @HopkinsMedicine and @hopkinskimmel on the next-generation of cancer screening through machine vision and artificial intelligence.
ow.ly/2CuH50uSU4N
Congrats to @CamdenNexus co-founders @RJVneurotech and @georgecpetro who are among six biotech leaders honored at this year’s @BaltBizOnline's Tech10 Awards!
ow.ly/t1fN50uR5jS
Camden Partners Nexus portfolio company, Thrive Earlier Detection Corp., among Maryland's largest #venturecapital rounds AND the largest #VC sum seen in #Maryland this year! #biotech #cancerdetection @georgecpetro @RJVneurotech ›› ow.ly/dWdU50uBNVf
















